SCHEMBL4861215

SCHEMBL4861215

CCCC(Nc1ccc(OCCn2c(CC)nc(-c3ccccc3)cc2=O)cc1)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.40
PPARA Q07869 3/20 0.40
GSK3B P49841 1/20 0.39
PLA2G2A P14555 1/20 0.39
PDE10A Q9Y233 1/20 0.39
PTGES O14684 1/20 0.37
ALOX5 P09917 1/20 0.37
MAPT P10636 4/20 0.36
TDP1 Q9NUW8 3/20 0.36
NPC1 O15118 2/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LTB4R Q15722 1/20 0.36
ALDH1A1 P00352 3/20 0.36
KMT2A Q03164 3/20 0.36
KDM4E B2RXH2 2/20 0.36
HTT P42858 2/20 0.36
HSP90AA1 P07900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849238 0.92 P2RY12 (0.39) PPARGPPARAGSK3BPLA2G2APDE10A
SCHEMBL4856378 0.89 LTB4R (0.39) PPARGPPARAGSK3BPLA2G2APDE10A
SCHEMBL14263765 0.87 GSK3B (0.38) GSK3BPLA2G2APDE10AMAPTTDP1
SCHEMBL4857868 0.85 PPARG (0.48) PPARGPPARAGSK3BPLA2G2APDE10A
SCHEMBL4859967 0.85 ELANE (0.38) PPARGPPARAGSK3BPLA2G2APDE10A
SCHEMBL14263764 0.84 GSK3B (0.38) GSK3BPLA2G2AMAPTTDP1NPC1
SCHEMBL4858080 0.82 GSK3B (0.38) GSK3BPLA2G2APDE10AMAPTTDP1
SCHEMBL4850885 0.81 PPARG (0.39) PPARGPPARAGSK3BPLA2G2APDE10A
SCHEMBL4850624 0.79 PPARA (0.41) PPARAGSK3BPLA2G2APDE10AMAPT
SCHEMBL4859287 0.79 PPARG (0.48) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7348334-B2 Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2008-03-25 US claimed
US-20030013729-A1 New monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LTD. 2003-01-16 US claimed
US-7348334-B2 Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2008-03-25 US disclosed
US-7348334-B2 Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2008-03-25 US disclosed
US-20030013729-A1 New monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LTD. 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013729-A1 New monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them GPR119, FFAR1, FFAR3 PPARG 86/4885PPARA 60/4885GSK3B 1097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.